← Back to Search

Behavioural Intervention

Sedentary Reduction Strategies for Sedentary Lifestyle (START Trial)

N/A

Recruiting

Led By Amal Wanigatunga, PhD

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults aged ≥65 years

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 months

Awards & highlights

START Trial Summary

This trial compares 2 ways to become less sedentary and more active in 60 older adults, to see which is easier to achieve and maintains them more active over time.

Who is the study for?

The START Trial is for adults aged 65 or older who are at risk of becoming frail but can still walk. They should be somewhat inactive, doing less than 20 minutes of physical activity per day, and willing to increase their walking time. People with severe health issues like uncontrolled high blood pressure, cognitive impairment, or those needing help to walk aren't eligible.Check my eligibility

What is being tested?

This trial tests two programs designed to reduce sitting time in seniors: one replaces it with a single daily 30-minute walk; the other splits this into three shorter walks throughout the day. The study will see which method is better over a period of 60 days for improving activity levels and overall well-being.See study design

What are the potential side effects?

Since the interventions involve light walking exercises, side effects might include typical exercise-related discomforts such as muscle soreness or fatigue initially. However, these activities are generally safe and beneficial for most seniors.

START Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

START Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Sedentary Time

Intervention Difference in the Change in Sedentary Time

Secondary outcome measures

Change in Anxiety

Change in Blood Glucose

Change in Exercise-based Self Efficacy

+20 more

START Trial Design

2Treatment groups

Active Control

Group I: Continuous sedentary reduction interventionActive Control1 Intervention

Structured intervention to progressively replace sedentary time with one daily 30-minute light-intensity walking bout

Group II: Bouted sedentary reduction interventionActive Control1 Intervention

Structured intervention to progressively replace sedentary time with three daily 10-minute light-intensity walking bouts

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,106,870 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,825 Total Patients Enrolled

19 Trials studying Sedentary Lifestyle

4,202 Patients Enrolled for Sedentary Lifestyle

Amal Wanigatunga, PhDPrincipal InvestigatorJohns Hopkins Blomberg School of Public Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the enrollment period for this investigation closed?

"The records accessible on clinicaltrials.gov state that this trial is not currently recruiting patients, having first been posted to the site in October of 2023 and last edited in September of the same year. However, there are 174 other trials actively searching for participants presently."

Answered by AI

What outcomes are hoped to be gleaned from this medical experiment?

"This research aims to analyse the impact of this particular intervention on sedentary time at baseline and 2 months later. Other key outcomes include changes in walking ability (measured as 400m walk), walking speed (4m), and fatigue level (as indicated by a 0-13 score questionnaire)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Sedentary to Active Rising to Thrive (START) Trial

2023. "The Sedentary to Active Rising to Thrive (START) Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06023680.